Proathlete Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Proathlete Wealth Management's AMGN Position: Q3 2026 in Review
Proathlete Wealth Management increased its Amgen (AMGN) stake by 500% in Q3 2026, buying an estimated $29.9K and bringing the position to 90 shares worth $37.9K. The position accounts for 0.01% of the portfolio, ranked #167.
Proathlete Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Proathlete Wealth Management held 90 shares of Amgen worth $37.9K as of Q3 2026.
- Proathlete Wealth Management bought 75 Amgen shares in Q3 2026, an estimated $29.9K.
- Amgen made up 0.01% of Proathlete Wealth Management's portfolio in Q3 2026, its #167 holding.
- Proathlete Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Proathlete Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.